Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Down 78.8% in August

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a large drop in short interest in the month of August. As of August 31st, there was short interest totaling 18,768 shares, a drop of 78.8% from the August 15th total of 88,674 shares. Approximately 0.8% of the shares of the stock are sold short. Based on an average daily volume of 183,620 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 25th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Get Arcadia Biosciences alerts:

Get Our Latest Analysis on Arcadia Biosciences

Arcadia Biosciences Stock Down 4.8%

NASDAQ RKDA traded down $0.02 during trading hours on Friday, reaching $0.43. The company’s stock had a trading volume of 19,052 shares, compared to its average volume of 125,251. The firm’s 50-day moving average price is $0.59 and its 200-day moving average price is $1.01. Arcadia Biosciences has a 1 year low of $0.38 and a 1 year high of $6.71. The company has a market capitalization of $1.04 million, a price-to-earnings ratio of -0.09 and a beta of 0.53.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.56) by ($1.53). Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%. The company had revenue of $1.44 million for the quarter, compared to analysts’ expectations of $1.90 million.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

Featured Stories

• Five stocks we like better than Arcadia Biosciences
• Optical Cable Corporation Is Starting to Get the Market’s Attention
• Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
• Is Nike’s Index Demotion a Warning or a Buying Opportunity?
• American Eagle Goes on Sale: Is It Time to Buy?

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.